Key Takeaways An immunotherapy drug can boost survival in people with stomach or esophageal cancerWhen combined with chemo, ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...

Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...